These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 1569886)

  • 1. Subcutaneous injection of oral cyclosporin A solution.
    Midha R; Mackinnon SE; Evans PJ; Best TJ; Wong PY
    Microsurgery; 1992; 13(2):92-4. PubMed ID: 1569886
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced oral cyclosporine absorption with water-soluble vitamin E early after liver transplantation.
    Pan SH; Lopez RR; Sher LS; Hoffman AL; Podesta LG; Makowka L; Rosenthal P
    Pharmacotherapy; 1996; 16(1):59-65. PubMed ID: 8700793
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of serum triglyceride concentration on the fluctuation of whole blood concentration of cyclosporin A in patients.
    Nakamura T; Kakumoto M; Sakaeda T; Nagahiro K; Ohmichi R; Yamashita K; Nishiguchi K; Hirai M; Okumura K
    Biol Pharm Bull; 2001 Jun; 24(6):683-7. PubMed ID: 11411559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Preparation of cyclosporine A pH sensitive nanoparticles and oral pharmacokinetics in rats].
    Dai JD; Wang XQ; Zhang T; Meng M; Zhang X; Lü WL; Zhang Q
    Yao Xue Xue Bao; 2004 Dec; 39(12):1023-7. PubMed ID: 15813034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. pH-sensitive nanoparticles for improving the oral bioavailability of cyclosporine A.
    Dai J; Nagai T; Wang X; Zhang T; Meng M; Zhang Q
    Int J Pharm; 2004 Aug; 280(1-2):229-40. PubMed ID: 15265562
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution kinetics of FK-506, a novel immunosuppressant, after intravenous administration to rats in comparison with cyclosporin A.
    Takada K; Usuda H; Oh-Hashi M
    Biopharm Drug Dispos; 1992 Jul; 13(5):345-55. PubMed ID: 1379839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of oral adsorbent AST-120 on cyclosporin absorption in rats.
    Takemoto M; Tsuchida M; Konishi M; Suga A; Iojima K; Naito K
    J Pharm Pharmacol; 1997 Jul; 49(7):657-60. PubMed ID: 9255707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tacrolimus versus cyclosporin A: a comparative study on rat renal allograft survival.
    Jiang H; Sakuma S; Fujii Y; Akiyama Y; Ogawa T; Tamura K; Kobayashi M; Fujitsu T
    Transpl Int; 1999; 12(2):92-9. PubMed ID: 10363590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic exposure to cyclosporine affects endothelial and smooth muscle reactivity in the rat aorta.
    Cartier R; Dagenais F; Hollmann C; Cambron H; Buluran J
    Ann Thorac Surg; 1994 Sep; 58(3):789-94. PubMed ID: 7944704
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Local dermal delivery of cyclosporin A, a hydrophobic and high molecular weight drug, using dissolving microneedles.
    Jeong HR; Kim JY; Kim SN; Park JH
    Eur J Pharm Biopharm; 2018 Jun; 127():237-243. PubMed ID: 29432892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Relative bioavailability of cyclosporine A-loaded hydroxypropyl methylcellulose phthalate nanoparticles for oral administration in rats].
    Wang XQ; Dai JD; Zhang Q; Zhang T; Xia GM
    Yao Xue Xue Bao; 2004 Jun; 39(6):463-6. PubMed ID: 15491107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic cyclosporin A therapy in rats.
    Midha R; Mackinnon SE; Wade JA; Evans PJ; Best TJ; Wong PY
    Microsurgery; 1992; 13(5):273-6. PubMed ID: 1406233
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pharmacokinetic comparison of the corn oil versus microemulsion gelcap formulation of cyclosporin used de novo after renal transplantation.
    Amante AJ; Meier-Kriesche HU; Schoenberg L; Kahan BD
    Transpl Int; 1997; 10(3):217-22. PubMed ID: 9163863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states.
    Shibata N; Shimakawa H; Minouchi T; Yamaji A
    Biol Pharm Bull; 1993 Nov; 16(11):1130-5. PubMed ID: 8312870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiocidal effect of Cyclosporin A: a new therapeutic approach for pathogenic angiogenesis.
    Wilasrusmee C; Yusupov I; Ondocin P; Bruch D; Kittur S; Wilasrusmee S; Kittur DS
    Int Angiol; 2005 Dec; 24(4):372-9. PubMed ID: 16355096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats.
    Ueda CT; Lemaire M; Gsell G; Nussbaumer K
    Biopharm Drug Dispos; 1983; 4(2):113-24. PubMed ID: 6882880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bioavailability and pharmacokinetics of cyclosporine A-loaded pH-sensitive nanoparticles for oral administration.
    Wang XQ; Dai JD; Chen Z; Zhang T; Xia GM; Nagai T; Zhang Q
    J Control Release; 2004 Jul; 97(3):421-9. PubMed ID: 15212874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concentration-guided strategies in drug development: experience with a cyclosporine analog in transplantation.
    Kovarik JM; Mueller EA; Kallay Z; Smith HT; Lison AE; Arns W; Renner E
    J Clin Pharmacol; 1995 Dec; 35(12):1136-43. PubMed ID: 8750363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apparent dose-dependent oral absorption of cyclosporin A in rats.
    Ueda CT; Lemaire M; Gsell G; Misslin P; Nussbaumer K
    Biopharm Drug Dispos; 1984; 5(2):141-51. PubMed ID: 6743782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the therapeutic range of whole blood cyclosporin concentration in the treatment of psoriasis.
    Ieiri I; Nakayama J; Murakami H; Hori Y; Higuchi S
    Int J Clin Pharmacol Ther; 1996 Mar; 34(3):106-11. PubMed ID: 8705088
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.